207 related articles for article (PubMed ID: 19169921)
1. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.
Shenoy VS; Rajyaguru TH; Gude RP; Murthy RS
J Microencapsul; 2009 Sep; 26(6):471-8. PubMed ID: 19169921
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.
Shenoy VS; Gude RP; Murthy RS
J Drug Target; 2009 May; 17(4):304-10. PubMed ID: 19255897
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
Lee MK; Lim SJ; Kim CK
Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
5. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
Thirupathi G; Swetha E; Narendar D
Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake and antitumour activity of paclitaxel incorporated into trilaurin-based solid lipid nanoparticles in ovarian cancer.
Xu W; Lim SJ; Lee MK
J Microencapsul; 2013; 30(8):755-61. PubMed ID: 23594306
[TBL] [Abstract][Full Text] [Related]
7. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
[TBL] [Abstract][Full Text] [Related]
8. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
[TBL] [Abstract][Full Text] [Related]
9. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
12. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
Athawale RB; Jain DS; Singh KK; Gude RP
Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
[TBL] [Abstract][Full Text] [Related]
13. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
Trivino A; Gumireddy A; Chauhan H
AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
[TBL] [Abstract][Full Text] [Related]
14. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
Vivek K; Reddy H; Murthy RS
AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
Yuan H; Miao J; Du YZ; You J; Hu FQ; Zeng S
Int J Pharm; 2008 Feb; 348(1-2):137-45. PubMed ID: 17714896
[TBL] [Abstract][Full Text] [Related]
16. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
[TBL] [Abstract][Full Text] [Related]
18. Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection--preparation, characterisation and in vivo evaluation.
Rao MP; Manjunath K; Bhagawati ST; Thippeswamy BS
Int J Pharm; 2014 Oct; 473(1-2):485-92. PubMed ID: 25066077
[TBL] [Abstract][Full Text] [Related]
19. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
